1	STOCKHOLM	stockholm	NNP	p2=VB	6	npadvmod	6:AM-TMP
2	-	-	:	p2=,	6	punct	_
3	The	the	DT	_	5	det	_
4	Swedish	swedish	JJ	_	5	amod	_
5	government	government	NN	_	6	nsubj	6:A0=PAG;34:A0=PAG
6	launched	launch	VBD	pb=launch.01	0	root	_
7	a	a	DT	_	8	det	_
8	fightback	fightback	NN	_	6	dobj	6:A1=PPT
9	on	on	IN	_	6	prep	6:AM-TMP
10	Friday	friday	NNP	_	9	pobj	_
11	against	against	IN	_	6	prep	_
12	US	us	NNP	_	14	nn	_
13	drugmaker	drugmaker	NNP	p2=NN	14	nn	_
14	Pfizer	pfizer	NNP	_	17	poss	_
15	's	's	POS	_	14	possessive	_
16	proposed	propose	VBN	p2=JJ|pb=propose.01	17	amod	_
17	takeover	takeover	NN	_	11	pobj	16:A1=PPT
18	of	of	IN	_	17	prep	_
19	AstraZeneca	astrazeneca	NNP	_	18	pobj	22:A0=PAG
20	,	,	,	_	19	punct	_
21	which	which	WDT	_	22	nsubj	22:R-A0
22	has	have	VBZ	pb=have.03	19	rcmod	_
23	half	half	PDT	p2=VBN	25	predet	_
24	its	its	PRP$	_	25	poss	_
25	roots	root	NNS	_	22	dobj	22:A1=PPT
26	and	and	CC	_	25	cc	_
27	more	more	JJR	_	29	amod	_
28	than	than	IN	_	29	quantmod	_
29	5,000	0	CD	_	30	num	_
30	staff	staff	NN	_	25	conj	_
31	in	in	IN	_	30	prep	_
32	Sweden	sweden	NNP	_	31	pobj	_
33	,	,	,	_	6	punct	_
34	highlighting	highlight	VBG	pb=highlight.01	6	advcl	6:AM-ADV
35	the	the	DT	_	36	det	_
36	risks	risk	NNS	_	34	dobj	34:A1=PPT
37	to	to	IN	_	34	prep	34:A2=GOL
38	jobs	job	NNS	_	37	pobj	_
39	and	and	CC	_	38	cc	_
40	science	science	NN	_	38	conj	_
41	.	.	.	_	6	punct	_

1	In	in	IN	_	17	prep	17:AM-LOC
2	an	an	DT	_	4	det	_
3	unusual	unusual	JJ	_	4	amod	_
4	move	move	NN	_	1	pobj	_
5	for	for	IN	_	4	prep	_
6	the	the	DT	_	8	det	_
7	centre-right	centre-right	JJ	_	8	amod	_
8	government	government	NN	_	5	pobj	10:A0
9	which	which	WDT	_	10	nsubj	10:R-A0
10	favours	favour	VBZ	p2=VBP|pb=favour.01	8	rcmod	_
11	an	an	DT	_	13	det	_
12	open	open	JJ	_	13	amod	_
13	economy	economy	NN	_	10	dobj	10:A1
14	,	,	,	_	17	punct	_
15	three	#crd#	CD	_	16	num	_
16	ministers	minister	NNS	_	17	nsubj	17:A0=PAG;28:A0=PAG
17	spoke	speak	VBD	pb=speak.03	0	root	_
18	out	out	RP	p2=RB	17	prt	17:C-V
19	against	against	IN	_	17	prep	17:A1=PPT
20	the	the	DT	_	21	det	_
21	deal	deal	NN	_	19	pobj	_
22	at	at	IN	_	17	prep	17:AM-LOC
23	a	a	DT	_	26	det	_
24	joint	joint	JJ	_	26	amod	_
25	press	press	NN	_	26	nn	_
26	conference	conference	NN	_	22	pobj	_
27	,	,	,	_	17	punct	_
28	pointing	point	VBG	pb=point.01	17	advcl	17:AM-ADV
29	to	to	IN	_	28	prep	28:A2=GOL
30	Pfizer	pfizer	NNP	_	32	poss	_
31	's	's	POS	_	30	possessive	_
32	history	history	NN	_	29	pobj	_
33	of	of	IN	_	32	prep	_
34	job	job	NN	_	35	nn	_
35	cuts	cut	NNS	_	33	pobj	_
36	after	after	IN	_	35	prep	_
37	previous	previous	JJ	_	38	amod	_
38	acquisitions	acquisition	NNS	_	36	pobj	_
39	.	.	.	_	17	punct	_

1	The	the	DT	_	5	det	_
2	three	#crd#	CD	_	4	hmod	_
3	-	-	HYPH	p2=.	4	hyph	_
4	Finance	finance	NNP	p2=NN	5	nn	_
5	Minister	minister	NNP	_	7	nn	_
6	Anders	anders	NNP	p2=NNPS	7	nn	_
7	Borg	borg	NNP	_	19	nsubj	19:A0
8	,	,	,	_	7	punct	_
9	Enterprise	enterprise	NNP	_	10	nn	_
10	Minister	minister	NNP	_	12	nn	_
11	Annie	annie	NNP	_	12	nn	_
12	Loof	loof	NNP	_	7	conj	_
13	and	and	CC	_	12	cc	_
14	Education	education	NNP	_	15	nn	_
15	Minister	minister	NNP	_	17	nn	_
16	Jan	jan	NNP	_	29	nn	_
17	Bjorklund	bjorklund	NNP	_	19	nsubj	_
18	-	-	HYPH	p2=,	17	punct	_
19	said	say	VBD	p2=VBN|pb=say.01	0	root	_
20	AstraZeneca	astrazeneca	NNP	_	22	poss	_
21	's	's	POS	_	20	possessive	_
22	shareholders	shareholder	NNS	_	26	nsubj	26:A0=PAG;27:A0=PAG
23	should	should	MD	_	26	aux	26:AM-MOD
24	"	"	``	_	26	punct	_
25	seriously	seriously	RB	_	26	advmod	26:AM-MNR
26	consider	consider	VB	pb=consider.02	19	ccomp	19:A1=PPT
27	rejecting	reject	VBG	pb=reject.01	26	xcomp	26:A1=PPT
28	"	"	``	_	27	punct	_
29	Pfizer	pfizer	NNP	_	31	poss	_
30	's	's	POS	_	29	possessive	_
31	plan	plan	NN	_	27	dobj	27:A1=PPT
32	.	.	.	_	19	punct	_

1	"	"	``	_	31	punct	_
2	We	we	PRP	_	4	nsubj	4:A0
3	are	be	VBP	_	4	aux	_
4	saying	say	VBG	pb=say.01	31	ccomp	31:A1=PPT
5	that	that	IN	_	7	complm	_
6	there	there	EX	_	7	expl	_
7	are	be	VBP	pb=be.02	4	ccomp	4:A1=PPT
8	risks	risk	NNS	_	7	attr	7:A1=PPT
9	in	in	IN	_	8	prep	_
10	terms	term	NNS	_	9	pobj	_
11	of	of	IN	_	10	prep	_
12	Swedish	swedish	JJ	_	13	amod	_
13	research	research	NN	_	11	pobj	_
14	,	,	,	_	13	punct	_
15	the	the	DT	_	19	det	_
16	entire	entire	JJ	_	19	amod	_
17	life	life	NN	_	18	nn	_
18	science	science	NN	_	19	nn	_
19	cluster	cluster	NN	_	13	conj	_
20	,	,	,	_	19	punct	_
21	and	and	CC	_	19	cc	_
22	also	also	RB	_	21	advmod	_
23	potentially	potentially	RB	_	24	advmod	_
24	jobs	job	NNS	_	19	conj	_
25	in	in	IN	_	24	prep	_
26	Sweden	sweden	NNP	_	25	pobj	_
27	,	,	,	_	31	punct	_
28	"	"	''	p2=``	31	punct	_
29	Mr	mr	NNP	_	30	nn	_
30	Borg	borg	NNP	_	31	nsubj	31:A0
31	said	say	VBD	pb=say.01	0	root	_
32	.	.	.	_	31	punct	_

1	AstraZeneca	astrazeneca	NNP	_	17	nsubj	17:A0=PAG;5:A1=PPT
2	,	,	,	_	1	punct	_
3	which	which	WDT	_	5	nsubjpass	5:R-A1
4	was	be	VBD	_	5	auxpass	_
5	formed	form	VBN	pb=form.01	1	rcmod	_
6	from	from	IN	_	5	prep	5:A2=VSP
7	an	an	DT	_	11	det	_
8	Anglo	anglo	JJ	p2=NNP	10	hmod	_
9	-	-	HYPH	_	10	hyph	_
10	Swedish	swedish	JJ	_	11	amod	_
11	merger	merger	NN	_	6	pobj	_
12	15	0	CD	_	13	num	_
13	years	year	NNS	_	14	npadvmod	_
14	ago	ago	RB	_	11	advmod	_
15	,	,	,	_	17	punct	_
16	has	have	VBZ	_	17	aux	_
17	rebuffed	rebuff	VBN	pb=rebuff.01	0	root	_
18	Pfizer	pfizer	NNP	_	21	poss	_
19	's	's	POS	_	18	possessive	_
20	current	current	JJ	p2=NN	21	amod	_
21	offer	offer	NN	_	17	dobj	17:A1=PPT
22	but	but	CC	_	17	cc	_
23	the	the	DT	_	25	det	_
24	US	us	NNP	_	25	nn	_
25	group	group	NN	_	28	nsubjpass	28:A1=PPT;30:A1=PPT
26	is	be	VBZ	_	28	auxpass	_
27	widely	widely	RB	_	28	advmod	28:AM-MNR
28	expected	expect	VBN	pb=expect.01	17	conj	_
29	to	to	TO	_	30	aux	_
30	return	return	VB	pb=return.01	28	xcomp	28:C-A1
31	with	with	IN	_	30	prep	30:AM-MNR
32	a	a	DT	_	34	det	_
33	sweetened	sweeten	VBN	pb=sweeten.02	34	amod	_
34	bid	bid	NN	p2=VBN	31	pobj	33:A1=PPT
35	.	.	.	_	28	punct	_

1	AstraZeneca	astrazeneca	NNP	_	3	poss	_
2	's	's	POS	p2=VBZ	1	possessive	_
3	CE	ce	NNP	_	6	nsubj	6:A0=PAG
4	has	have	VBZ	_	6	aux	_
5	not	not	RB	_	6	neg	6:AM-NEG
6	ruled	rule	VBN	pb=rule.02	0	root	_
7	out	out	RP	_	6	prt	6:C-V
8	discussions	discussion	NNS	_	6	dobj	6:A1=PPT
9	at	at	IN	_	8	prep	_
10	the	the	DT	_	12	det	_
11	right	right	JJ	_	12	amod	_
12	price	price	NN	_	9	pobj	_
13	.	.	.	_	6	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nsubj	3:A0=PAG
2	has	have	VBZ	_	3	aux	_
3	given	give	VBN	pb=give.01	0	root	_
4	a	a	DT	_	8	det	_
5	five	#crd#	CD	_	7	hmod	_
6	-	-	HYPH	_	7	hyph	_
7	year	year	NN	_	8	nn	_
8	promise	promise	NN	p2=VBP	3	dobj	3:A1=PPT
9	to	to	TO	_	10	aux	_
10	have	have	VB	pb=have.03	8	infmod	_
11	20	0	CD	_	12	num	_
12	%	%	NN	_	10	dobj	10:A1=PPT
13	of	of	IN	_	12	prep	_
14	its	its	PRP$	_	16	poss	_
15	research	research	NN	_	16	nn	_
16	staff	staff	NN	_	13	pobj	_
17	in	in	IN	_	10	prep	_
18	Britain	britain	NNP	_	17	pobj	22:AM-LOC
19	,	,	,	_	18	punct	_
20	where	where	WRB	_	22	advmod	22:R-AM-LOC
21	AstraZeneca	astrazeneca	NNP	_	22	nsubj	22:A0=PAG
22	has	have	VBZ	pb=have.03	18	rcmod	_
23	its	its	PRP$	_	24	poss	_
24	headquarters	headquarter	NNS	p2=NN	22	dobj	22:A1=PPT
25	,	,	,	_	3	punct	_
26	but	but	CC	_	3	cc	_
27	it	it	PRP	_	30	nsubj	30:A0=PAG
28	has	have	VBZ	_	30	aux	_
29	not	not	RB	_	30	neg	30:AM-NEG
30	spelt	spell	VBN	p2=VB|pb=spell.03	3	conj	_
31	out	out	RP	_	30	prt	30:C-V
32	what	what	WP	_	34	dobj	34:R-A1
33	this	this	DT	_	34	nsubj	34:A0=PAG
34	means	mean	VBZ	pb=mean.01	30	ccomp	30:A1=PPT
35	in	in	IN	_	34	prep	34:AM-LOC
36	absolute	absolute	JJ	_	37	amod	_
37	numbers	number	NNS	_	35	pobj	_
38	.	.	.	_	30	punct	_

1	At	at	IN	_	10	prep	10:AM-TMP
2	the	the	DT	_	4	det	_
3	same	same	JJ	_	4	amod	_
4	time	time	NN	_	1	pobj	_
5	,	,	,	_	10	punct	_
6	the	the	DT	_	8	det	_
7	American	american	JJ	_	8	amod	_
8	company	company	NN	_	10	nsubj	10:A0
9	has	have	VBZ	_	10	aux	_
10	said	say	VBN	pb=say.01	0	root	_
11	that	that	IN	_	21	complm	_
12	the	the	DT	_	15	det	_
13	overall	overall	JJ	_	15	amod	_
14	research	research	NN	_	15	nn	_
15	budget	budget	NN	_	21	nsubj	21:A1=PPT
16	of	of	IN	_	15	prep	_
17	a	a	DT	_	19	det	_
18	merged	merged	JJ	p2=VBN	19	amod	_
19	group	group	NN	_	16	pobj	_
20	would	would	MD	_	21	aux	21:AM-MOD
21	be	be	VB	pb=be.01	10	ccomp	10:A1=PPT
22	lower	low	JJR	_	21	acomp	21:A2=PRD
23	than	than	IN	_	22	prep	_
24	the	the	DT	_	25	det	_
25	sum	sum	NN	_	23	pobj	_
26	of	of	IN	_	25	prep	_
27	the	the	DT	_	29	det	_
28	two	#crd#	CD	_	29	num	_
29	companies	company	NNS	_	33	poss	_
30	'	'	POS	_	29	possessive	_
31	individual	individual	JJ	p2=NN	33	amod	_
32	research	research	NN	_	33	nn	_
33	budgets	budget	NNS	_	26	pobj	_
34	.	.	.	_	10	punct	_

1	The	the	DT	_	2	det	_
2	numbers	number	NNS	_	3	nsubj	3:A0=PAG
3	suggest	suggest	VBP	pb=suggest.01	0	root	_
4	Sweden	sweden	NNP	_	5	nsubj	5:A1=PPT;8:A1=PPT
5	is	be	VBZ	pb=be.01	3	ccomp	3:A1=PPT
6	right	right	JJ	_	5	acomp	5:A2=PRD
7	to	to	TO	_	8	aux	_
8	be	be	VB	pb=be.01	6	xcomp	_
9	worried	worried	JJ	p2=VBN	8	acomp	8:A2=PRD
10	.	.	.	_	3	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nsubj	3:A0=PAG
2	currently	currently	RB	_	3	advmod	3:AM-TMP
3	has	have	VBZ	pb=have.03	0	root	_
4	about	about	IN	p2=RB	5	advmod	_
5	11,000	0	CD	_	6	num	_
6	staff	staff	NN	_	3	dobj	7:A0=PAG;3:A1=PPT
7	working	work	VBG	pb=work.01	6	partmod	_
8	in	in	IN	_	7	prep	7:AM-LOC
9	research	research	NN	_	8	pobj	_
10	worldwide	worldwide	RB	_	7	advmod	7:AM-LOC
11	,	,	,	_	3	punct	_
12	while	while	IN	_	14	mark	_
13	AstraZeneca	astrazeneca	NNP	_	14	nsubj	14:A0=PAG
14	has	have	VBZ	pb=have.03	3	advcl	3:AM-ADV
15	9,000	0	CD	_	14	dobj	14:A1=PPT
16	,	,	,	_	3	punct	_
17	and	and	CC	_	3	cc	_
18	the	the	DT	_	20	det	_
19	two	#crd#	CD	_	20	num	_
20	companies	company	NNS	_	22	nsubj	22:A0=PAG
21	together	together	RB	_	22	advmod	22:AM-TMP
22	employ	employ	VBP	p2=VB|pb=employ.01	3	conj	_
23	3,450	0	CD	_	22	dobj	22:A1=PPT
24	in	in	IN	_	22	prep	22:AM-TMP
25	the	the	DT	_	28	det	_
26	UK	uk	NNP	_	28	hmod	_
27	-	-	HYPH	_	28	hyph	_
28	2,600	0	CD	p2=NNP	24	pobj	_
29	at	at	IN	_	22	prep	22:AM-LOC
30	AstraZeneca	astrazeneca	NNP	_	29	pobj	_
31	and	and	CC	_	22	cc	_
32	850	0	CD	_	22	conj	_
33	at	at	IN	_	32	prep	_
34	Pfizer	pfizer	NNP	_	36	hmod	_
35	-	-	HYPH	p2=:	36	hyph	_
36	representing	represent	VBG	_	38	amod	_
37	17.25	0	CD	_	38	num	_
38	%	%	NN	_	33	pobj	_
39	of	of	IN	_	38	prep	_
40	the	the	DT	_	42	det	_
41	combined	combine	VBN	p2=JJ|pb=combine.01	42	amod	_
42	total	total	NN	p2=JJ	39	pobj	41:A1=PPT
43	.	.	.	_	22	punct	_

1	But	but	CC	_	3	cc	3:AM-DIS
2	AstraZeneca	astrazeneca	NNP	_	3	nsubj	3:A0=PAG;5:A0=DIR;23:A0=PAG
3	plans	plan	VBZ	p2=NNS|pb=plan.01	0	root	_
4	to	to	TO	_	5	aux	_
5	shed	shed	VB	p2=VBD|pb=shed.01	3	xcomp	3:A1=PPT
6	400	0	CD	_	8	num	_
7	research	research	NN	_	8	nn	_
8	posts	post	NNS	_	5	dobj	5:A1=PPT
9	by	by	IN	_	5	prep	5:AM-TMP
10	2016	0	CD	_	9	pobj	_
11	as	as	IN	_	13	mark	_
12	it	it	PRP	_	13	nsubj	13:A1=PPT
13	moves	move	VBZ	pb=move.01	5	advcl	5:AM-TMP
14	to	to	IN	_	13	prep	13:A2=GOL
15	a	a	DT	_	17	det	_
16	new	new	JJ	_	17	amod	_
17	site	site	NN	_	14	pobj	_
18	in	in	IN	_	17	prep	_
19	Cambridge	cambridge	NNP	_	18	pobj	_
20	,	,	,	_	19	punct	_
21	UK	uk	NNP	_	19	appos	_
22	,	,	,	_	5	punct	_
23	suggesting	suggest	VBG	pb=suggest.01	5	advcl	_
24	that	that	IN	p2=DT	33	complm	_
25	research	research	NN	_	26	nn	_
26	centres	center	NNS	p2=VBZ	33	nsubj	35:A0
27	in	in	IN	_	26	prep	_
28	Sweden	sweden	NNP	_	27	pobj	_
29	and	and	CC	_	28	cc	_
30	the	the	DT	_	31	det	_
31	US	us	NNP	_	28	conj	_
32	will	will	MD	_	33	aux	33:AM-MOD
33	have	have	VB	pb=have.02	23	ccomp	23:A1=PPT
34	to	to	TO	_	35	aux	_
35	take	take	VB	pb=take.01	33	xcomp	_
36	a	a	DT	_	38	det	_
37	larger	large	JJR	_	38	amod	_
38	share	share	NN	_	35	dobj	35:A1=PPT
39	of	of	IN	_	38	prep	_
40	future	future	JJ	p2=NN	42	amod	_
41	job	job	NN	_	42	nn	_
42	cuts	cut	NNS	p2=VBZ	39	pobj	_
43	if	if	IN	_	45	mark	_
44	Pfizer	pfizer	NNP	_	45	nsubj	47:A0=PAG;45:A1=PPT
45	is	be	VBZ	pb=be.01	33	advcl	_
46	to	to	TO	_	47	aux	_
47	hit	hit	VB	pb=hit.02	45	xcomp	45:A2=PRD
48	its	its	PRP$	_	51	poss	_
49	20	0	CD	_	50	num	_
50	%	%	NN	_	51	nn	_
51	target	target	NN	_	47	dobj	47:A1=GOL
52	.	.	.	_	3	punct	_

1	In	in	IN	_	5	prep	5:AM-LOC
2	Sweden	sweden	NNP	_	1	pobj	_
3	,	,	,	_	5	punct	_
4	AstraZeneca	astrazeneca	NNP	_	5	nsubj	5:A0=PAG
5	employs	employ	VBZ	pb=employ.01	0	root	_
6	5,900	0	CD	_	7	num	_
7	people	people	NNS	_	5	dobj	5:A1=PPT
8	,	,	,	_	7	punct	_
9	of	of	IN	_	4	prep	_
10	whom	whom	WP	_	9	pobj	_
11	2,200	0	CD	_	12	num	_
12	work	work	NN	p2=VBP	5	dobj	_
13	in	in	IN	_	12	prep	_
14	research	research	NN	_	13	pobj	_
15	and	and	CC	_	14	cc	_
16	development	development	NN	_	14	conj	_
17	(	(	-LRB-	_	18	punct	_
18	R&D	r&d	NN	p2=NNP	12	appos	_
19	)	)	-RRB-	_	18	punct	_
20	.	.	.	_	5	punct	_

1	Mr	mr	NNP	_	2	nn	_
2	Borg	borg	NNP	_	6	nsubj	6:A0
3	and	and	CC	_	2	cc	_
4	Mr	mr	NNP	_	5	nn	_
5	Bjorklund	bjorklund	NNP	_	2	conj	_
6	said	say	VBD	pb=say.01	0	root	_
7	they	they	PRP	_	9	nsubj	9:A0=PAG
8	had	have	VBD	_	9	aux	_
9	spoken	speak	VBN	pb=speak.01	6	ccomp	6:A1=PPT
10	to	to	IN	_	9	prep	9:A2=GOL
11	the	the	DT	_	13	det	_
12	British	british	JJ	_	13	amod	_
13	government	government	NN	_	10	pobj	_
14	about	about	IN	_	9	prep	9:A1=PPT
15	their	their	PRP$	_	16	poss	_
16	concerns	concern	NNS	_	14	pobj	_
17	that	that	IN	_	22	complm	_
18	the	the	DT	_	19	det	_
19	deal	deal	NN	_	22	nsubjpass	22:A1=PPT
20	was	be	VBD	_	22	auxpass	_
21	largely	largely	RB	_	22	advmod	22:AM-ADV
22	motivated	motivate	VBN	p2=JJ|pb=motivate.01	16	ccomp	_
23	by	by	IN	_	22	agent	22:A0=PAG
24	tax	tax	NN	_	23	pobj	_
25	and	and	CC	_	24	cc	_
26	cost	cost	NN	_	28	hmod	_
27	-	-	HYPH	_	28	hyph	_
28	cutting	cut	VBG	p2=NN	29	amod	_
29	priorities	priority	NNS	_	24	conj	_
30	.	.	.	_	6	punct	_

1	They	they	PRP	_	3	nsubj	3:A0=PAG
2	also	also	RB	_	3	advmod	3:AM-DIS
3	pointed	point	VBD	pb=point.01	0	root	_
4	to	to	IN	_	3	prep	3:A2=GOL
5	the	the	DT	_	6	det	_
6	experience	experience	NN	_	4	pobj	_
7	of	of	IN	_	6	prep	_
8	Pfizer	pfizer	NNP	_	9	nsubj	9:A0=PAG
9	buying	buy	VBG	pb=buy.01	7	pcomp	_
10	Pharmacia	pharmacia	NNP	_	9	dobj	13:A0=PAG;9:A1=PPT
11	,	,	,	_	10	punct	_
12	which	which	WDT	_	13	nsubj	13:R-A0
13	led	lead	VBD	pb=lead.03	10	rcmod	_
14	to	to	IN	_	13	prep	13:A2=PRD
15	big	big	JJ	_	17	amod	_
16	research	research	NN	_	17	nn	_
17	cutbacks	cutback	NNS	_	14	pobj	_
18	.	.	.	_	3	punct	_

1	Sweden	sweden	NNP	_	2	nsubj	_
2	has	have	VBZ	_	8	aux	_
3	,	,	,	_	2	punct	_
4	in	in	IN	_	2	prep	_
5	the	the	DT	_	6	det	_
6	past	past	NN	_	4	pobj	_
7	,	,	,	_	2	punct	_
8	been	be	VBN	pb=be.01	0	root	_
9	reluctant	reluctant	JJ	_	8	acomp	8:A2=PRD
10	to	to	TO	_	11	aux	_
11	agree	agree	VB	pb=agree.01	9	xcomp	_
12	to	to	IN	_	11	prep	11:A1=PPT
13	European	european	NNP	_	14	nn	_
14	Union	union	NNP	_	15	nn	_
15	rules	rule	NNS	p2=VBZ	12	pobj	18:A0=PAG
16	that	that	WDT	_	18	nsubj	18:R-A0
17	would	would	MD	_	18	aux	18:AM-MOD
18	require	require	VB	pb=require.01	15	rcmod	_
19	public	public	JJ	_	20	amod	_
20	interest	interest	NN	_	21	nn	_
21	tests	test	NNS	_	18	dobj	18:A1=PPT
22	for	for	IN	_	21	prep	_
23	business	business	NN	_	24	nn	_
24	deals	deal	NNS	_	22	pobj	_
25	,	,	,	_	8	punct	_
26	but	but	CC	_	8	cc	_
27	Mr	mr	NNP	_	28	nn	_
28	Borg	borg	NNP	_	29	nsubj	29:A0
29	said	say	VBD	pb=say.01	8	conj	_
30	Pfizer	pfizer	NNP	_	34	poss	_
31	's	's	POS	_	30	possessive	_
32	"	"	``	_	34	punct	_
33	semihostile	semihostile	NN	p2=JJ	34	nn	_
34	bid	bid	NN	_	37	nsubj	37:A0=PAG
35	"	"	''	_	34	punct	_
36	might	might	MD	_	37	aux	37:AM-MOD
37	force	force	VB	pb=force.02	29	ccomp	29:A1=PPT
38	a	a	DT	_	39	det	_
39	rethink	rethink	NN	p2=VB	37	dobj	37:A1=PPT
40	.	.	.	_	29	punct	_

1	"	"	``	_	5	punct	_
2	Essentially	essentially	RB	_	5	advmod	_
3	,	,	,	_	5	punct	_
4	we	we	PRP	_	5	nsubj	5:A0=PAG;7:A0=PAG
5	want	want	VBP	pb=want.01	41	ccomp	41:A1=PPT
6	to	to	TO	_	7	aux	_
7	retain	retain	VB	pb=retain.01	5	xcomp	5:A1=PPT
8	an	an	DT	_	10	det	_
9	open	open	JJ	_	10	amod	_
10	regime	regime	NN	_	7	dobj	7:A1=PPT
11	,	,	,	_	5	punct	_
12	but	but	CC	_	5	cc	_
13	at	at	IN	_	31	prep	31:AM-TMP
14	the	the	DT	_	16	det	_
15	same	same	JJ	_	16	amod	_
16	time	time	NN	_	13	pobj	_
17	,	,	,	_	31	punct	_
18	if	if	IN	_	20	mark	_
19	you	you	PRP	_	20	nsubj	20:A0=PAG
20	behave	behave	VBP	pb=behave.01	31	advcl	31:AM-ADV
21	in	in	IN	_	20	prep	20:A1=PRD
22	the	the	DT	_	23	det	_
23	way	way	NN	_	21	pobj	27:AM-MNR
24	that	that	WDT	p2=WRB	27	dobj	27:R-A1
25	Pfizer	pfizer	NNP	_	27	nsubj	27:A0=PAG
26	is	be	VBZ	_	27	aux	_
27	doing	do	VBG	pb=do.02	23	rcmod	_
28	,	,	,	_	31	punct	_
29	then	then	RB	_	31	advmod	31:AM-TMP
30	you	you	PRP	_	31	nsubj	31:A0=PAG
31	undermine	undermine	VBP	pb=undermine.01	5	conj	_
32	the	the	DT	_	33	det	_
33	legitimacy	legitimacy	NN	_	31	dobj	31:A1=PPT
34	of	of	IN	_	33	prep	_
35	that	that	DT	_	37	det	_
36	open	open	JJ	_	37	amod	_
37	regime	regime	NN	_	34	pobj	_
38	,	,	,	_	41	punct	_
39	"	"	''	_	41	punct	_
40	he	he	PRP	_	41	nsubj	41:A0=PAG
41	told	tell	VBD	pb=tell.01	0	root	_
42	reporters	reporter	NNS	_	41	dobj	41:A2=GOL
43	.	.	.	_	41	punct	_

1	Mr	mr	NNP	_	2	nn	_
2	Borg	borg	NNP	_	15	nsubj	15:A0=PAG
3	,	,	,	_	2	punct	_
4	Prime	prime	NNP	_	5	nn	_
5	Minister	minister	NNP	_	7	nn	_
6	Fredrik	fredrik	NNP	_	7	nn	_
7	Reinfeldt	reinfeldt	NNP	_	2	conj	_
8	and	and	CC	_	7	cc	_
9	opposition	opposition	NN	_	10	nn	_
10	leader	leader	NN	_	12	nn	_
11	Stefan	stefan	NNP	_	12	nn	_
12	Lofven	lofven	NNP	_	7	conj	_
13	have	have	VBP	_	15	aux	_
14	previously	previously	RB	_	15	advmod	15:AM-TMP
15	expressed	express	VBN	pb=express.01	0	root	_
16	fears	fear	NNS	p2=VBZ	15	dobj	15:A1=PPT
17	the	the	DT	_	20	det	_
18	$	$	$	p2=NN	19	nmod	_
19	106bn	0bn	CD	p2=JJ	20	nn	_
20	approach	approach	NN	_	22	nsubj	22:A0=PAG
21	would	would	MD	_	22	aux	22:AM-MOD
22	lead	lead	VB	pb=lead.03	16	ccomp	_
23	to	to	IN	_	22	prep	22:A2=PRD
24	job	job	NN	_	25	nn	_
25	losses	loss	NNS	_	23	pobj	_
26	in	in	IN	_	25	prep	_
27	Sweden	sweden	NNP	_	26	pobj	_
28	.	.	.	_	15	punct	_

1	Mr	mr	NNP	_	2	nn	_
2	Borg	borg	NNP	_	9	nsubj	9:A0
3	,	,	,	_	2	punct	_
4	Ms	ms	NNP	p2=NNPS	5	nn	_
5	Loof	loof	NNP	_	2	conj	_
6	and	and	CC	_	5	cc	_
7	Mr	mr	NNP	_	8	nn	_
8	Bjorklund	bjorklund	NNP	_	5	conj	_
9	said	say	VBD	pb=say.01	0	root	_
10	in	in	IN	_	9	prep	9:AM-LOC
11	a	a	DT	_	14	det	_
12	signed	sign	VBN	p2=JJ|pb=sign.02	14	amod	_
13	opinion	opinion	NN	_	14	nn	_
14	piece	piece	NN	_	10	pobj	12:A1=PPT
15	in	in	IN	_	14	prep	_
16	the	the	DT	_	19	det	_
17	Wall	wall	NNP	_	18	nn	_
18	Street	street	NNP	_	19	nn	_
19	Journal	journal	NNP	_	15	pobj	_
20	that	that	IN	p2=WDT	33	complm	_
21	the	the	DT	_	22	det	_
22	guarantees	guarantee	NNS	_	33	nsubj	23:A1=PPT;33:A1=PPT
23	offered	offer	VBN	pb=offer.01	22	partmod	_
24	by	by	IN	_	23	agent	23:A0=PAG
25	Pfizer	pfizer	NNP	_	24	pobj	_
26	over	over	IN	_	23	prep	23:AM-TMP
27	retaining	retain	VBG	pb=retain.01	26	pcomp	_
28	research	research	NN	_	27	dobj	27:A1=PPT
29	and	and	CC	_	28	cc	_
30	jobs	job	NNS	_	28	conj	_
31	in	in	IN	_	30	prep	_
32	Europe	europe	NNP	_	31	pobj	_
33	were	be	VBD	pb=be.01	9	ccomp	9:A1=PPT
34	not	not	RB	_	33	neg	33:AM-NEG
35	sufficient	sufficient	JJ	_	33	acomp	33:A2=PRD
36	.	.	.	_	9	punct	_

1	STOCKHOLM	stockholm	NNP	p2=VB	6	npadvmod	6:AM-TMP
2	-	-	:	p2=,	6	punct	_
3	The	the	DT	_	5	det	_
4	Swedish	swedish	JJ	_	5	amod	_
5	government	government	NN	_	6	nsubj	6:A0=PAG;34:A0=PAG
6	launched	launch	VBD	pb=launch.01	0	root	_
7	a	a	DT	_	8	det	_
8	fightback	fightback	NN	_	6	dobj	6:A1=PPT
9	on	on	IN	_	6	prep	6:AM-TMP
10	Friday	friday	NNP	_	9	pobj	_
11	against	against	IN	_	6	prep	_
12	US	us	NNP	_	14	nn	_
13	drugmaker	drugmaker	NNP	p2=NN	14	nn	_
14	Pfizer	pfizer	NNP	_	17	poss	_
15	's	's	POS	_	14	possessive	_
16	proposed	propose	VBN	p2=JJ|pb=propose.01	17	amod	_
17	takeover	takeover	NN	_	11	pobj	16:A1=PPT
18	of	of	IN	_	17	prep	_
19	AstraZeneca	astrazeneca	NNP	_	18	pobj	22:A0=PAG
20	,	,	,	_	19	punct	_
21	which	which	WDT	_	22	nsubj	22:R-A0
22	has	have	VBZ	pb=have.03	19	rcmod	_
23	half	half	PDT	p2=VBN	25	predet	_
24	its	its	PRP$	_	25	poss	_
25	roots	root	NNS	_	22	dobj	22:A1=PPT
26	and	and	CC	_	25	cc	_
27	more	more	JJR	_	29	amod	_
28	than	than	IN	_	29	quantmod	_
29	5,000	0	CD	_	30	num	_
30	staff	staff	NN	_	25	conj	_
31	in	in	IN	_	30	prep	_
32	Sweden	sweden	NNP	_	31	pobj	_
33	,	,	,	_	6	punct	_
34	highlighting	highlight	VBG	pb=highlight.01	6	advcl	6:AM-ADV
35	the	the	DT	_	36	det	_
36	risks	risk	NNS	_	34	dobj	34:A1=PPT
37	to	to	IN	_	34	prep	34:A2=GOL
38	jobs	job	NNS	_	37	pobj	_
39	and	and	CC	_	38	cc	_
40	science	science	NN	_	38	conj	_
41	.	.	.	_	6	punct	_

1	In	in	IN	_	17	prep	17:AM-LOC
2	an	an	DT	_	4	det	_
3	unusual	unusual	JJ	_	4	amod	_
4	move	move	NN	_	1	pobj	_
5	for	for	IN	_	4	prep	_
6	the	the	DT	_	8	det	_
7	centre-right	centre-right	JJ	_	8	amod	_
8	government	government	NN	_	5	pobj	10:A0
9	which	which	WDT	_	10	nsubj	10:R-A0
10	favours	favour	VBZ	p2=VBP|pb=favour.01	8	rcmod	_
11	an	an	DT	_	13	det	_
12	open	open	JJ	_	13	amod	_
13	economy	economy	NN	_	10	dobj	10:A1
14	,	,	,	_	17	punct	_
15	three	#crd#	CD	_	16	num	_
16	ministers	minister	NNS	_	17	nsubj	17:A0=PAG;28:A0=PAG
17	spoke	speak	VBD	pb=speak.03	0	root	_
18	out	out	RP	p2=RB	17	prt	17:C-V
19	against	against	IN	_	17	prep	17:A1=PPT
20	the	the	DT	_	21	det	_
21	deal	deal	NN	_	19	pobj	_
22	at	at	IN	_	17	prep	17:AM-LOC
23	a	a	DT	_	26	det	_
24	joint	joint	JJ	_	26	amod	_
25	press	press	NN	_	26	nn	_
26	conference	conference	NN	_	22	pobj	_
27	,	,	,	_	17	punct	_
28	pointing	point	VBG	pb=point.01	17	advcl	17:AM-ADV
29	to	to	IN	_	28	prep	28:A2=GOL
30	Pfizer	pfizer	NNP	_	32	poss	_
31	's	's	POS	_	30	possessive	_
32	history	history	NN	_	29	pobj	_
33	of	of	IN	_	32	prep	_
34	job	job	NN	_	35	nn	_
35	cuts	cut	NNS	_	33	pobj	_
36	after	after	IN	_	35	prep	_
37	previous	previous	JJ	_	38	amod	_
38	acquisitions	acquisition	NNS	_	36	pobj	_
39	.	.	.	_	17	punct	_

1	The	the	DT	_	5	det	_
2	three	#crd#	CD	_	4	hmod	_
3	-	-	HYPH	p2=.	4	hyph	_
4	Finance	finance	NNP	p2=NN	5	nn	_
5	Minister	minister	NNP	_	7	nn	_
6	Anders	anders	NNP	p2=NNPS	7	nn	_
7	Borg	borg	NNP	_	19	nsubj	19:A0
8	,	,	,	_	7	punct	_
9	Enterprise	enterprise	NNP	_	10	nn	_
10	Minister	minister	NNP	_	12	nn	_
11	Annie	annie	NNP	_	12	nn	_
12	Loof	loof	NNP	_	7	conj	_
13	and	and	CC	_	12	cc	_
14	Education	education	NNP	_	15	nn	_
15	Minister	minister	NNP	_	17	nn	_
16	Jan	jan	NNP	_	29	nn	_
17	Bjorklund	bjorklund	NNP	_	19	nsubj	_
18	-	-	HYPH	p2=,	17	punct	_
19	said	say	VBD	p2=VBN|pb=say.01	0	root	_
20	AstraZeneca	astrazeneca	NNP	_	22	poss	_
21	's	's	POS	_	20	possessive	_
22	shareholders	shareholder	NNS	_	26	nsubj	26:A0=PAG;27:A0=PAG
23	should	should	MD	_	26	aux	26:AM-MOD
24	"	"	``	_	26	punct	_
25	seriously	seriously	RB	_	26	advmod	26:AM-MNR
26	consider	consider	VB	pb=consider.02	19	ccomp	19:A1=PPT
27	rejecting	reject	VBG	pb=reject.01	26	xcomp	26:A1=PPT
28	"	"	``	_	27	punct	_
29	Pfizer	pfizer	NNP	_	31	poss	_
30	's	's	POS	_	29	possessive	_
31	plan	plan	NN	_	27	dobj	27:A1=PPT
32	.	.	.	_	19	punct	_

1	"	"	``	_	31	punct	_
2	We	we	PRP	_	4	nsubj	4:A0
3	are	be	VBP	_	4	aux	_
4	saying	say	VBG	pb=say.01	31	ccomp	31:A1=PPT
5	that	that	IN	_	7	complm	_
6	there	there	EX	_	7	expl	_
7	are	be	VBP	pb=be.02	4	ccomp	4:A1=PPT
8	risks	risk	NNS	_	7	attr	7:A1=PPT
9	in	in	IN	_	8	prep	_
10	terms	term	NNS	_	9	pobj	_
11	of	of	IN	_	10	prep	_
12	Swedish	swedish	JJ	_	13	amod	_
13	research	research	NN	_	11	pobj	_
14	,	,	,	_	13	punct	_
15	the	the	DT	_	19	det	_
16	entire	entire	JJ	_	19	amod	_
17	life	life	NN	_	18	nn	_
18	science	science	NN	_	19	nn	_
19	cluster	cluster	NN	_	13	conj	_
20	,	,	,	_	19	punct	_
21	and	and	CC	_	19	cc	_
22	also	also	RB	_	21	advmod	_
23	potentially	potentially	RB	_	24	advmod	_
24	jobs	job	NNS	_	19	conj	_
25	in	in	IN	_	24	prep	_
26	Sweden	sweden	NNP	_	25	pobj	_
27	,	,	,	_	31	punct	_
28	"	"	''	p2=``	31	punct	_
29	Mr	mr	NNP	_	30	nn	_
30	Borg	borg	NNP	_	31	nsubj	31:A0
31	said	say	VBD	pb=say.01	0	root	_
32	.	.	.	_	31	punct	_

1	AstraZeneca	astrazeneca	NNP	_	17	nsubj	17:A0=PAG;5:A1=PPT
2	,	,	,	_	1	punct	_
3	which	which	WDT	_	5	nsubjpass	5:R-A1
4	was	be	VBD	_	5	auxpass	_
5	formed	form	VBN	pb=form.01	1	rcmod	_
6	from	from	IN	_	5	prep	5:A2=VSP
7	an	an	DT	_	11	det	_
8	Anglo	anglo	JJ	p2=NNP	10	hmod	_
9	-	-	HYPH	_	10	hyph	_
10	Swedish	swedish	JJ	_	11	amod	_
11	merger	merger	NN	_	6	pobj	_
12	15	0	CD	_	13	num	_
13	years	year	NNS	_	14	npadvmod	_
14	ago	ago	RB	_	11	advmod	_
15	,	,	,	_	17	punct	_
16	has	have	VBZ	_	17	aux	_
17	rebuffed	rebuff	VBN	pb=rebuff.01	0	root	_
18	Pfizer	pfizer	NNP	_	21	poss	_
19	's	's	POS	_	18	possessive	_
20	current	current	JJ	p2=NN	21	amod	_
21	offer	offer	NN	_	17	dobj	17:A1=PPT
22	but	but	CC	_	17	cc	_
23	the	the	DT	_	25	det	_
24	US	us	NNP	_	25	nn	_
25	group	group	NN	_	28	nsubjpass	28:A1=PPT;30:A1=PPT
26	is	be	VBZ	_	28	auxpass	_
27	widely	widely	RB	_	28	advmod	28:AM-MNR
28	expected	expect	VBN	pb=expect.01	17	conj	_
29	to	to	TO	_	30	aux	_
30	return	return	VB	pb=return.01	28	xcomp	28:C-A1
31	with	with	IN	_	30	prep	30:AM-MNR
32	a	a	DT	_	34	det	_
33	sweetened	sweeten	VBN	pb=sweeten.02	34	amod	_
34	bid	bid	NN	p2=VBN	31	pobj	33:A1=PPT
35	.	.	.	_	28	punct	_

1	AstraZeneca	astrazeneca	NNP	_	3	poss	_
2	's	's	POS	p2=VBZ	1	possessive	_
3	CE	ce	NNP	_	6	nsubj	6:A0=PAG
4	has	have	VBZ	_	6	aux	_
5	not	not	RB	_	6	neg	6:AM-NEG
6	ruled	rule	VBN	pb=rule.02	0	root	_
7	out	out	RP	_	6	prt	6:C-V
8	discussions	discussion	NNS	_	6	dobj	6:A1=PPT
9	at	at	IN	_	8	prep	_
10	the	the	DT	_	12	det	_
11	right	right	JJ	_	12	amod	_
12	price	price	NN	_	9	pobj	_
13	.	.	.	_	6	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nsubj	3:A0=PAG
2	has	have	VBZ	_	3	aux	_
3	given	give	VBN	pb=give.01	0	root	_
4	a	a	DT	_	8	det	_
5	five	#crd#	CD	_	7	hmod	_
6	-	-	HYPH	_	7	hyph	_
7	year	year	NN	_	8	nn	_
8	promise	promise	NN	p2=VBP	3	dobj	3:A1=PPT
9	to	to	TO	_	10	aux	_
10	have	have	VB	pb=have.03	8	infmod	_
11	20	0	CD	_	12	num	_
12	%	%	NN	_	10	dobj	10:A1=PPT
13	of	of	IN	_	12	prep	_
14	its	its	PRP$	_	16	poss	_
15	research	research	NN	_	16	nn	_
16	staff	staff	NN	_	13	pobj	_
17	in	in	IN	_	10	prep	_
18	Britain	britain	NNP	_	17	pobj	22:AM-LOC
19	,	,	,	_	18	punct	_
20	where	where	WRB	_	22	advmod	22:R-AM-LOC
21	AstraZeneca	astrazeneca	NNP	_	22	nsubj	22:A0=PAG
22	has	have	VBZ	pb=have.03	18	rcmod	_
23	its	its	PRP$	_	24	poss	_
24	headquarters	headquarter	NNS	p2=NN	22	dobj	22:A1=PPT
25	,	,	,	_	3	punct	_
26	but	but	CC	_	3	cc	_
27	it	it	PRP	_	30	nsubj	30:A0=PAG
28	has	have	VBZ	_	30	aux	_
29	not	not	RB	_	30	neg	30:AM-NEG
30	spelt	spell	VBN	p2=VB|pb=spell.03	3	conj	_
31	out	out	RP	_	30	prt	30:C-V
32	what	what	WP	_	34	dobj	34:R-A1
33	this	this	DT	_	34	nsubj	34:A0=PAG
34	means	mean	VBZ	pb=mean.01	30	ccomp	30:A1=PPT
35	in	in	IN	_	34	prep	34:AM-LOC
36	absolute	absolute	JJ	_	37	amod	_
37	numbers	number	NNS	_	35	pobj	_
38	.	.	.	_	30	punct	_

1	At	at	IN	_	10	prep	10:AM-TMP
2	the	the	DT	_	4	det	_
3	same	same	JJ	_	4	amod	_
4	time	time	NN	_	1	pobj	_
5	,	,	,	_	10	punct	_
6	the	the	DT	_	8	det	_
7	American	american	JJ	_	8	amod	_
8	company	company	NN	_	10	nsubj	10:A0
9	has	have	VBZ	_	10	aux	_
10	said	say	VBN	pb=say.01	0	root	_
11	that	that	IN	_	21	complm	_
12	the	the	DT	_	15	det	_
13	overall	overall	JJ	_	15	amod	_
14	research	research	NN	_	15	nn	_
15	budget	budget	NN	_	21	nsubj	21:A1=PPT
16	of	of	IN	_	15	prep	_
17	a	a	DT	_	19	det	_
18	merged	merged	JJ	p2=VBN	19	amod	_
19	group	group	NN	_	16	pobj	_
20	would	would	MD	_	21	aux	21:AM-MOD
21	be	be	VB	pb=be.01	10	ccomp	10:A1=PPT
22	lower	low	JJR	_	21	acomp	21:A2=PRD
23	than	than	IN	_	22	prep	_
24	the	the	DT	_	25	det	_
25	sum	sum	NN	_	23	pobj	_
26	of	of	IN	_	25	prep	_
27	the	the	DT	_	29	det	_
28	two	#crd#	CD	_	29	num	_
29	companies	company	NNS	_	33	poss	_
30	'	'	POS	_	29	possessive	_
31	individual	individual	JJ	p2=NN	33	amod	_
32	research	research	NN	_	33	nn	_
33	budgets	budget	NNS	_	26	pobj	_
34	.	.	.	_	10	punct	_

1	The	the	DT	_	2	det	_
2	numbers	number	NNS	_	3	nsubj	3:A0=PAG
3	suggest	suggest	VBP	pb=suggest.01	0	root	_
4	Sweden	sweden	NNP	_	5	nsubj	5:A1=PPT;8:A1=PPT
5	is	be	VBZ	pb=be.01	3	ccomp	3:A1=PPT
6	right	right	JJ	_	5	acomp	5:A2=PRD
7	to	to	TO	_	8	aux	_
8	be	be	VB	pb=be.01	6	xcomp	_
9	worried	worried	JJ	p2=VBN	8	acomp	8:A2=PRD
10	.	.	.	_	3	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nsubj	3:A0=PAG
2	currently	currently	RB	_	3	advmod	3:AM-TMP
3	has	have	VBZ	pb=have.03	0	root	_
4	about	about	IN	p2=RB	5	advmod	_
5	11,000	0	CD	_	6	num	_
6	staff	staff	NN	_	3	dobj	7:A0=PAG;3:A1=PPT
7	working	work	VBG	pb=work.01	6	partmod	_
8	in	in	IN	_	7	prep	7:AM-LOC
9	research	research	NN	_	8	pobj	_
10	worldwide	worldwide	RB	_	7	advmod	7:AM-LOC
11	,	,	,	_	3	punct	_
12	while	while	IN	_	14	mark	_
13	AstraZeneca	astrazeneca	NNP	_	14	nsubj	14:A0=PAG
14	has	have	VBZ	pb=have.03	3	advcl	3:AM-ADV
15	9,000	0	CD	_	14	dobj	14:A1=PPT
16	,	,	,	_	3	punct	_
17	and	and	CC	_	3	cc	_
18	the	the	DT	_	20	det	_
19	two	#crd#	CD	_	20	num	_
20	companies	company	NNS	_	22	nsubj	22:A0=PAG
21	together	together	RB	_	22	advmod	22:AM-TMP
22	employ	employ	VBP	p2=VB|pb=employ.01	3	conj	_
23	3,450	0	CD	_	22	dobj	22:A1=PPT
24	in	in	IN	_	22	prep	22:AM-TMP
25	the	the	DT	_	28	det	_
26	UK	uk	NNP	_	28	hmod	_
27	-	-	HYPH	_	28	hyph	_
28	2,600	0	CD	p2=NNP	24	pobj	_
29	at	at	IN	_	22	prep	22:AM-LOC
30	AstraZeneca	astrazeneca	NNP	_	29	pobj	_
31	and	and	CC	_	22	cc	_
32	850	0	CD	_	22	conj	_
33	at	at	IN	_	32	prep	_
34	Pfizer	pfizer	NNP	_	36	hmod	_
35	-	-	HYPH	p2=:	36	hyph	_
36	representing	represent	VBG	_	38	amod	_
37	17.25	0	CD	_	38	num	_
38	%	%	NN	_	33	pobj	_
39	of	of	IN	_	38	prep	_
40	the	the	DT	_	42	det	_
41	combined	combine	VBN	p2=JJ|pb=combine.01	42	amod	_
42	total	total	NN	p2=JJ	39	pobj	41:A1=PPT
43	.	.	.	_	22	punct	_

1	But	but	CC	_	3	cc	3:AM-DIS
2	AstraZeneca	astrazeneca	NNP	_	3	nsubj	3:A0=PAG;5:A0=DIR;23:A0=PAG
3	plans	plan	VBZ	p2=NNS|pb=plan.01	0	root	_
4	to	to	TO	_	5	aux	_
5	shed	shed	VB	p2=VBD|pb=shed.01	3	xcomp	3:A1=PPT
6	400	0	CD	_	8	num	_
7	research	research	NN	_	8	nn	_
8	posts	post	NNS	_	5	dobj	5:A1=PPT
9	by	by	IN	_	5	prep	5:AM-TMP
10	2016	0	CD	_	9	pobj	_
11	as	as	IN	_	13	mark	_
12	it	it	PRP	_	13	nsubj	13:A1=PPT
13	moves	move	VBZ	pb=move.01	5	advcl	5:AM-TMP
14	to	to	IN	_	13	prep	13:A2=GOL
15	a	a	DT	_	17	det	_
16	new	new	JJ	_	17	amod	_
17	site	site	NN	_	14	pobj	_
18	in	in	IN	_	17	prep	_
19	Cambridge	cambridge	NNP	_	18	pobj	_
20	,	,	,	_	19	punct	_
21	UK	uk	NNP	_	19	appos	_
22	,	,	,	_	5	punct	_
23	suggesting	suggest	VBG	pb=suggest.01	5	advcl	_
24	that	that	IN	p2=DT	33	complm	_
25	research	research	NN	_	26	nn	_
26	centres	center	NNS	p2=VBZ	33	nsubj	35:A0
27	in	in	IN	_	26	prep	_
28	Sweden	sweden	NNP	_	27	pobj	_
29	and	and	CC	_	28	cc	_
30	the	the	DT	_	31	det	_
31	US	us	NNP	_	28	conj	_
32	will	will	MD	_	33	aux	33:AM-MOD
33	have	have	VB	pb=have.02	23	ccomp	23:A1=PPT
34	to	to	TO	_	35	aux	_
35	take	take	VB	pb=take.01	33	xcomp	_
36	a	a	DT	_	38	det	_
37	larger	large	JJR	_	38	amod	_
38	share	share	NN	_	35	dobj	35:A1=PPT
39	of	of	IN	_	38	prep	_
40	future	future	JJ	p2=NN	42	amod	_
41	job	job	NN	_	42	nn	_
42	cuts	cut	NNS	p2=VBZ	39	pobj	_
43	if	if	IN	_	45	mark	_
44	Pfizer	pfizer	NNP	_	45	nsubj	47:A0=PAG;45:A1=PPT
45	is	be	VBZ	pb=be.01	33	advcl	_
46	to	to	TO	_	47	aux	_
47	hit	hit	VB	pb=hit.02	45	xcomp	45:A2=PRD
48	its	its	PRP$	_	51	poss	_
49	20	0	CD	_	50	num	_
50	%	%	NN	_	51	nn	_
51	target	target	NN	_	47	dobj	47:A1=GOL
52	.	.	.	_	3	punct	_

1	In	in	IN	_	5	prep	5:AM-LOC
2	Sweden	sweden	NNP	_	1	pobj	_
3	,	,	,	_	5	punct	_
4	AstraZeneca	astrazeneca	NNP	_	5	nsubj	5:A0=PAG
5	employs	employ	VBZ	pb=employ.01	0	root	_
6	5,900	0	CD	_	7	num	_
7	people	people	NNS	_	5	dobj	5:A1=PPT
8	,	,	,	_	7	punct	_
9	of	of	IN	_	4	prep	_
10	whom	whom	WP	_	9	pobj	_
11	2,200	0	CD	_	12	num	_
12	work	work	NN	p2=VBP	5	dobj	_
13	in	in	IN	_	12	prep	_
14	research	research	NN	_	13	pobj	_
15	and	and	CC	_	14	cc	_
16	development	development	NN	_	14	conj	_
17	(	(	-LRB-	_	18	punct	_
18	R&D	r&d	NN	p2=NNP	12	appos	_
19	)	)	-RRB-	_	18	punct	_
20	.	.	.	_	5	punct	_

1	Mr	mr	NNP	_	2	nn	_
2	Borg	borg	NNP	_	6	nsubj	6:A0
3	and	and	CC	_	2	cc	_
4	Mr	mr	NNP	_	5	nn	_
5	Bjorklund	bjorklund	NNP	_	2	conj	_
6	said	say	VBD	pb=say.01	0	root	_
7	they	they	PRP	_	9	nsubj	9:A0=PAG
8	had	have	VBD	_	9	aux	_
9	spoken	speak	VBN	pb=speak.01	6	ccomp	6:A1=PPT
10	to	to	IN	_	9	prep	9:A2=GOL
11	the	the	DT	_	13	det	_
12	British	british	JJ	_	13	amod	_
13	government	government	NN	_	10	pobj	_
14	about	about	IN	_	9	prep	9:A1=PPT
15	their	their	PRP$	_	16	poss	_
16	concerns	concern	NNS	_	14	pobj	_
17	that	that	IN	_	22	complm	_
18	the	the	DT	_	19	det	_
19	deal	deal	NN	_	22	nsubjpass	22:A1=PPT
20	was	be	VBD	_	22	auxpass	_
21	largely	largely	RB	_	22	advmod	22:AM-ADV
22	motivated	motivate	VBN	p2=JJ|pb=motivate.01	16	ccomp	_
23	by	by	IN	_	22	agent	22:A0=PAG
24	tax	tax	NN	_	23	pobj	_
25	and	and	CC	_	24	cc	_
26	cost	cost	NN	_	28	hmod	_
27	-	-	HYPH	_	28	hyph	_
28	cutting	cut	VBG	p2=NN	29	amod	_
29	priorities	priority	NNS	_	24	conj	_
30	.	.	.	_	6	punct	_

1	They	they	PRP	_	3	nsubj	3:A0=PAG
2	also	also	RB	_	3	advmod	3:AM-DIS
3	pointed	point	VBD	pb=point.01	0	root	_
4	to	to	IN	_	3	prep	3:A2=GOL
5	the	the	DT	_	6	det	_
6	experience	experience	NN	_	4	pobj	_
7	of	of	IN	_	6	prep	_
8	Pfizer	pfizer	NNP	_	9	nsubj	9:A0=PAG
9	buying	buy	VBG	pb=buy.01	7	pcomp	_
10	Pharmacia	pharmacia	NNP	_	9	dobj	13:A0=PAG;9:A1=PPT
11	,	,	,	_	10	punct	_
12	which	which	WDT	_	13	nsubj	13:R-A0
13	led	lead	VBD	pb=lead.03	10	rcmod	_
14	to	to	IN	_	13	prep	13:A2=PRD
15	big	big	JJ	_	17	amod	_
16	research	research	NN	_	17	nn	_
17	cutbacks	cutback	NNS	_	14	pobj	_
18	.	.	.	_	3	punct	_

1	Sweden	sweden	NNP	_	2	nsubj	_
2	has	have	VBZ	_	8	aux	_
3	,	,	,	_	2	punct	_
4	in	in	IN	_	2	prep	_
5	the	the	DT	_	6	det	_
6	past	past	NN	_	4	pobj	_
7	,	,	,	_	2	punct	_
8	been	be	VBN	pb=be.01	0	root	_
9	reluctant	reluctant	JJ	_	8	acomp	8:A2=PRD
10	to	to	TO	_	11	aux	_
11	agree	agree	VB	pb=agree.01	9	xcomp	_
12	to	to	IN	_	11	prep	11:A1=PPT
13	European	european	NNP	_	14	nn	_
14	Union	union	NNP	_	15	nn	_
15	rules	rule	NNS	p2=VBZ	12	pobj	18:A0=PAG
16	that	that	WDT	_	18	nsubj	18:R-A0
17	would	would	MD	_	18	aux	18:AM-MOD
18	require	require	VB	pb=require.01	15	rcmod	_
19	public	public	JJ	_	20	amod	_
20	interest	interest	NN	_	21	nn	_
21	tests	test	NNS	_	18	dobj	18:A1=PPT
22	for	for	IN	_	21	prep	_
23	business	business	NN	_	24	nn	_
24	deals	deal	NNS	_	22	pobj	_
25	,	,	,	_	8	punct	_
26	but	but	CC	_	8	cc	_
27	Mr	mr	NNP	_	28	nn	_
28	Borg	borg	NNP	_	29	nsubj	29:A0
29	said	say	VBD	pb=say.01	8	conj	_
30	Pfizer	pfizer	NNP	_	34	poss	_
31	's	's	POS	_	30	possessive	_
32	"	"	``	_	34	punct	_
33	semihostile	semihostile	NN	p2=JJ	34	nn	_
34	bid	bid	NN	_	37	nsubj	37:A0=PAG
35	"	"	''	_	34	punct	_
36	might	might	MD	_	37	aux	37:AM-MOD
37	force	force	VB	pb=force.02	29	ccomp	29:A1=PPT
38	a	a	DT	_	39	det	_
39	rethink	rethink	NN	p2=VB	37	dobj	37:A1=PPT
40	.	.	.	_	29	punct	_

1	"	"	``	_	5	punct	_
2	Essentially	essentially	RB	_	5	advmod	_
3	,	,	,	_	5	punct	_
4	we	we	PRP	_	5	nsubj	5:A0=PAG;7:A0=PAG
5	want	want	VBP	pb=want.01	41	ccomp	41:A1=PPT
6	to	to	TO	_	7	aux	_
7	retain	retain	VB	pb=retain.01	5	xcomp	5:A1=PPT
8	an	an	DT	_	10	det	_
9	open	open	JJ	_	10	amod	_
10	regime	regime	NN	_	7	dobj	7:A1=PPT
11	,	,	,	_	5	punct	_
12	but	but	CC	_	5	cc	_
13	at	at	IN	_	31	prep	31:AM-TMP
14	the	the	DT	_	16	det	_
15	same	same	JJ	_	16	amod	_
16	time	time	NN	_	13	pobj	_
17	,	,	,	_	31	punct	_
18	if	if	IN	_	20	mark	_
19	you	you	PRP	_	20	nsubj	20:A0=PAG
20	behave	behave	VBP	pb=behave.01	31	advcl	31:AM-ADV
21	in	in	IN	_	20	prep	20:A1=PRD
22	the	the	DT	_	23	det	_
23	way	way	NN	_	21	pobj	27:AM-MNR
24	that	that	WDT	p2=WRB	27	dobj	27:R-A1
25	Pfizer	pfizer	NNP	_	27	nsubj	27:A0=PAG
26	is	be	VBZ	_	27	aux	_
27	doing	do	VBG	pb=do.02	23	rcmod	_
28	,	,	,	_	31	punct	_
29	then	then	RB	_	31	advmod	31:AM-TMP
30	you	you	PRP	_	31	nsubj	31:A0=PAG
31	undermine	undermine	VBP	pb=undermine.01	5	conj	_
32	the	the	DT	_	33	det	_
33	legitimacy	legitimacy	NN	_	31	dobj	31:A1=PPT
34	of	of	IN	_	33	prep	_
35	that	that	DT	_	37	det	_
36	open	open	JJ	_	37	amod	_
37	regime	regime	NN	_	34	pobj	_
38	,	,	,	_	41	punct	_
39	"	"	''	_	41	punct	_
40	he	he	PRP	_	41	nsubj	41:A0=PAG
41	told	tell	VBD	pb=tell.01	0	root	_
42	reporters	reporter	NNS	_	41	dobj	41:A2=GOL
43	.	.	.	_	41	punct	_

1	Mr	mr	NNP	_	2	nn	_
2	Borg	borg	NNP	_	15	nsubj	15:A0=PAG
3	,	,	,	_	2	punct	_
4	Prime	prime	NNP	_	5	nn	_
5	Minister	minister	NNP	_	7	nn	_
6	Fredrik	fredrik	NNP	_	7	nn	_
7	Reinfeldt	reinfeldt	NNP	_	2	conj	_
8	and	and	CC	_	7	cc	_
9	opposition	opposition	NN	_	10	nn	_
10	leader	leader	NN	_	12	nn	_
11	Stefan	stefan	NNP	_	12	nn	_
12	Lofven	lofven	NNP	_	7	conj	_
13	have	have	VBP	_	15	aux	_
14	previously	previously	RB	_	15	advmod	15:AM-TMP
15	expressed	express	VBN	pb=express.01	0	root	_
16	fears	fear	NNS	p2=VBZ	15	dobj	15:A1=PPT
17	the	the	DT	_	20	det	_
18	$	$	$	p2=NN	19	nmod	_
19	106bn	0bn	CD	p2=JJ	20	nn	_
20	approach	approach	NN	_	22	nsubj	22:A0=PAG
21	would	would	MD	_	22	aux	22:AM-MOD
22	lead	lead	VB	pb=lead.03	16	ccomp	_
23	to	to	IN	_	22	prep	22:A2=PRD
24	job	job	NN	_	25	nn	_
25	losses	loss	NNS	_	23	pobj	_
26	in	in	IN	_	25	prep	_
27	Sweden	sweden	NNP	_	26	pobj	_
28	.	.	.	_	15	punct	_

1	Mr	mr	NNP	_	2	nn	_
2	Borg	borg	NNP	_	9	nsubj	9:A0
3	,	,	,	_	2	punct	_
4	Ms	ms	NNP	p2=NNPS	5	nn	_
5	Loof	loof	NNP	_	2	conj	_
6	and	and	CC	_	5	cc	_
7	Mr	mr	NNP	_	8	nn	_
8	Bjorklund	bjorklund	NNP	_	5	conj	_
9	said	say	VBD	pb=say.01	0	root	_
10	in	in	IN	_	9	prep	9:AM-LOC
11	a	a	DT	_	14	det	_
12	signed	sign	VBN	p2=JJ|pb=sign.02	14	amod	_
13	opinion	opinion	NN	_	14	nn	_
14	piece	piece	NN	_	10	pobj	12:A1=PPT
15	in	in	IN	_	14	prep	_
16	the	the	DT	_	19	det	_
17	Wall	wall	NNP	_	18	nn	_
18	Street	street	NNP	_	19	nn	_
19	Journal	journal	NNP	_	15	pobj	_
20	that	that	IN	p2=WDT	33	complm	_
21	the	the	DT	_	22	det	_
22	guarantees	guarantee	NNS	_	33	nsubj	23:A1=PPT;33:A1=PPT
23	offered	offer	VBN	pb=offer.01	22	partmod	_
24	by	by	IN	_	23	agent	23:A0=PAG
25	Pfizer	pfizer	NNP	_	24	pobj	_
26	over	over	IN	_	23	prep	23:AM-TMP
27	retaining	retain	VBG	pb=retain.01	26	pcomp	_
28	research	research	NN	_	27	dobj	27:A1=PPT
29	and	and	CC	_	28	cc	_
30	jobs	job	NNS	_	28	conj	_
31	in	in	IN	_	30	prep	_
32	Europe	europe	NNP	_	31	pobj	_
33	were	be	VBD	pb=be.01	9	ccomp	9:A1=PPT
34	not	not	RB	_	33	neg	33:AM-NEG
35	sufficient	sufficient	JJ	_	33	acomp	33:A2=PRD
36	.	.	.	_	9	punct	_

1	Should	should	MD	_	3	aux	3:AM-MOD
2	you	you	PRP	_	3	nsubj	3:A0=PPT
3	experience	experience	VB	pb=experience.01	16	ccomp	_
4	any	any	DT	_	6	det	_
5	technical	technical	JJ	_	6	amod	_
6	difficulties	difficulty	NNS	_	3	dobj	3:A1=PAG
7	on	on	IN	_	6	prep	_
8	either	either	DT	_	7	pobj	_
9	of	of	IN	_	8	prep	_
10	the	the	DT	_	13	det	_
11	above	above	JJ	_	13	amod	_
12	webcast	webcast	NN	p2=JJ	13	nn	_
13	options	option	NNS	_	9	pobj	_
14	,	,	,	_	16	punct	_
15	please	please	UH	_	16	intj	16:AM-DIS
16	use	use	VB	pb=use.01	0	root	_
17	an	an	DT	_	19	det	_
18	alternative	alternative	JJ	p2=NN	19	amod	_
19	option	option	NN	_	16	dobj	16:A1=PPT
20	.	.	.	_	16	punct	_

1	You	you	PRP	_	4	nsubj	4:A0=PAG;7:A0=PPT
2	can	can	MD	_	4	aux	4:AM-MOD;7:AM-MOD
3	only	only	RB	_	4	advmod	4:AM-ADV
4	set	set	VB	p2=VBN|pb=set.03	0	root	_
5	up	up	RP	_	4	prt	4:C-V
6	or	or	CC	_	4	cc	_
7	view	view	VB	pb=view.01	4	conj	_
8	your	your	PRP$	_	10	poss	_
9	share	share	NN	_	10	nn	_
10	watchlist	watchlist	NN	p2=VB	7	dobj	7:A1=PAG
11	when	when	WRB	_	14	advmod	14:R-AM-TMP
12	you	you	PRP	_	14	nsubjpass	14:A1=PPT
13	are	be	VBP	_	14	auxpass	_
14	logged	log	VBN	pb=log.01	7	advcl	7:AM-TMP
15	in	in	RP	p2=IN	14	prt	14:C-V
16	as	as	IN	_	14	prep	_
17	a	a	DT	_	19	det	_
18	registered	register	VBN	p2=JJ|pb=register.02	19	amod	_
19	user	user	NN	_	16	pobj	18:A1=PPT
20	.	.	.	_	4	punct	_

1	Thereafter	thereafter	RB	p2=IN	4	advmod	10:AM-DIS;4:AM-TMP
2	you	you	PRP	_	4	nsubj	4:A0=PAG;10:A0=PPT;15:A0=PAG
3	can	can	MD	_	4	aux	4:AM-MOD;10:AM-MOD
4	select	select	VB	pb=select.01	0	root	_
5	a	a	DT	_	6	det	_
6	list	list	NN	_	4	dobj	4:A1=PPT
7	of	of	IN	_	6	prep	_
8	companies	company	NNS	_	7	pobj	_
9	and	and	CC	_	4	cc	_
10	enter	enter	VB	p2=VBP|pb=enter.01	4	conj	_
11	your	your	PRP$	_	13	poss	_
12	share	share	NN	_	13	nn	_
13	details	detail	NNS	_	10	dobj	10:A1=LOC
14	to	to	TO	_	15	aux	_
15	monitor	monitor	VB	pb=monitor.01	10	advcl	10:AM-PRP
16	their	their	PRP$	_	17	poss	_
17	performance	performance	NN	_	15	dobj	15:A1=LOC
18	.	.	.	_	4	punct	_

1	You	you	PRP	_	4	nsubj	4:A0=PAG
2	can	can	MD	_	4	aux	4:AM-MOD
3	only	only	RB	_	4	advmod	4:AM-ADV
4	clip	clip	VB	pb=clip.02	0	root	_
5	articles	article	NNS	_	4	dobj	4:A1=PPT
6	when	when	WRB	_	9	advmod	9:R-AM-TMP
7	you	you	PRP	_	9	nsubjpass	9:A1=PPT
8	are	be	VBP	_	9	auxpass	_
9	logged	log	VBN	pb=log.01	4	advcl	4:AM-TMP
10	in	in	RP	p2=IN	9	prt	9:C-V
11	as	as	IN	_	9	prep	_
12	a	a	DT	_	14	det	_
13	registered	register	VBN	p2=JJ|pb=register.02	14	amod	_
14	user	user	NN	_	11	pobj	13:A1=PPT
15	.	.	.	_	4	punct	_

1	Thereafter	thereafter	RB	p2=IN	4	advmod	4:AM-TMP
2	you	you	PRP	_	4	nsubj	4:A0=PAG
3	can	can	MD	_	4	aux	4:AM-MOD
4	click	click	VB	pb=click.01	0	root	_
5	on	on	IN	_	4	prep	4:AM-LOC
6	the	the	DT	_	11	det	_
7	"	"	``	_	11	punct	_
8	Read	read	NNP	p2=VB	11	nn	_
9	later	later	RB	_	8	advmod	_
10	"	"	''	_	11	punct	_
11	icon	icon	NN	_	5	pobj	_
12	at	at	IN	_	11	prep	_
13	the	the	DT	_	14	det	_
14	top	top	NN	_	12	pobj	_
15	of	of	IN	_	14	prep	_
16	an	an	DT	_	17	det	_
17	article	article	NN	_	15	pobj	_
18	to	to	TO	_	19	aux	_
19	save	save	VB	pb=save.02	17	infmod	_
20	it	it	PRP	_	19	dobj	19:A1=PPT
21	to	to	IN	_	19	prep	19:A2=VSP
22	this	this	DT	_	23	det	_
23	area	area	NN	_	21	pobj	_
24	of	of	IN	_	23	prep	_
25	your	your	PRP$	_	26	poss	_
26	console	console	NN	_	24	pobj	_
27	,	,	,	_	26	punct	_
28	where	where	WRB	_	31	advmod	31:R-AM-LOC
29	you	you	PRP	_	31	nsubj	33:A0=PAG;31:A1=PPT
30	can	can	MD	_	31	aux	31:AM-MOD
31	return	return	VB	pb=return.01	26	rcmod	_
32	to	to	TO	_	33	aux	_
33	read	read	VB	pb=read.01	31	advcl	_
34	it	it	PRP	_	33	dobj	33:A1=PPT
35	at	at	IN	_	33	prep	33:AM-TMP
36	any	any	DT	_	37	det	_
37	time	time	NN	_	35	pobj	_
38	.	.	.	_	4	punct	_

